Bivirkninger rapporteret i 12- ugers RLS kliniske undersøgelser (ropinirol n=309, placebo n=307) 4. 8. 1. 1. 1. 1 Psykiatriske lidelser
Table 2 lists the adverse drug reactions reported for ropinirole in the 12-week clinical trials at ≥ 1.0% above the placebo rate or those reported uncommonly but known to be associated with ropinirole.